Symmetry Peak Management’s iShares Biotechnology ETF IBB Stock Holding History

Symmetry Peak Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,500	Closed	-$273K	–	139
2019 Q2	$273K	Buy	+2,500	New	+$266K	0.06%	141
2017 Q4	–	Sell	-21,000	Closed	-$2.33M	–	90
2017 Q3	$2.33M	Buy	21,000 +15,000	+250%	+$1.6M	0.27%	43
2017 Q2	$620K	Buy	+6,000	New	+$591K	0.08%	105
2017 Q1	–	Sell	-4,500	Closed	-$398K	–	143
2016 Q4	$398K	Buy	+4,500	New	+$410K	0.14%	72

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Symmetry Peak Management's IBB Position: Q3 2019 in Review

Symmetry Peak Management sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 2,500 shares — an estimated $273K sold.

Symmetry Peak Management first reported a position in IBB in Q4 2016 and held it in 4 quarters. The position peaked at $2.33M in Q3 2017. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Symmetry Peak Management reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
Symmetry Peak Management sold 2,500 iShares Biotechnology ETF shares in Q3 2019, an estimated $273K.
Symmetry Peak Management first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 4 quarters.
Symmetry Peak Management's iShares Biotechnology ETF position peaked at $2.33M in Q3 2017.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Symmetry Peak Management's 13F filing for Q3 2019, filed 14 Nov 2019.